DJ-1: A Potential Biomarker Related to Prognosis, Chemoresistance, and Expression of Microenvironmental Chemokine in HR-Positive Breast Cancer

Figure 2

DJ-1 expression in breast cancer tissues and cells: (a) the immunohistochemistry (IHC) images between breast tumor and normal tissues by two different DJ-1 antibodies from the human protein atlas were downloaded by the Hpar packages in R; (b) differential expression of DJ-1 in HR+, HER2+, or TNBC subtypes patients tumor samples compared to normal counterparts, respectively; (c) and (d) differential expression of DJ-1 in nontumorigenic breast epithelial cell line (MCF-10A), HR+/HER2− breast cancer cells (MCF-7 and T-47D), HER2+ breast cancer cells (SK-BR-3 and BT-474) or TNBC cells (MDA-MB-231 and MDA-MB-468) by qPCR and western blot.

(a)

(b)

(c)

(d)